These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

858 related items for PubMed ID: 27881659

  • 1. Glycosylphosphatidylinositol-Anchored Anti-HIV scFv Efficiently Protects CD4 T Cells from HIV-1 Infection and Deletion in hu-PBL Mice.
    Ye C, Wang W, Cheng L, Li G, Wen M, Wang Q, Zhang Q, Li D, Zhou P, Su L.
    J Virol; 2017 Feb 01; 91(3):. PubMed ID: 27881659
    [Abstract] [Full Text] [Related]

  • 2. Human immunodeficiency virus type 1 strains R5 and X4 induce different pathogenic effects in hu-PBL-SCID mice, depending on the state of activation/differentiation of human target cells at the time of primary infection.
    Fais S, Lapenta C, Santini SM, Spada M, Parlato S, Logozzi M, Rizza P, Belardelli F.
    J Virol; 1999 Aug 01; 73(8):6453-9. PubMed ID: 10400739
    [Abstract] [Full Text] [Related]

  • 3. Glycosyl-Phosphatidylinositol-Anchored Anti-HIV Env Single-Chain Variable Fragments Interfere with HIV-1 Env Processing and Viral Infectivity.
    Misra A, Gleeson E, Wang W, Ye C, Zhou P, Kimata JT.
    J Virol; 2018 Apr 01; 92(7):. PubMed ID: 29321330
    [Abstract] [Full Text] [Related]

  • 4. A Membrane-Anchored Short-Peptide Fusion Inhibitor Fully Protects Target Cells from Infections of Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.
    Tang X, Jin H, Chen Y, Li L, Zhu Y, Chong H, He Y.
    J Virol; 2019 Nov 15; 93(22):. PubMed ID: 31462566
    [Abstract] [Full Text] [Related]

  • 5. Cell membrane-anchored anti-HIV single-chain antibodies and bifunctional inhibitors targeting the gp41 fusion protein: new strategies for HIV gene therapy.
    Chen Y, Jin H, Tang X, Li L, Geng X, Zhu Y, Chong H, He Y.
    Emerg Microbes Infect; 2022 Dec 15; 11(1):30-49. PubMed ID: 34821542
    [Abstract] [Full Text] [Related]

  • 6. Engineered CD4 T cells expressing a membrane anchored viral inhibitor restrict HIV-1 through cis and trans mechanisms.
    Wang W, Truong K, Ye C, Sharma S, He H, Liu L, Wen M, Misra A, Zhou P, Kimata JT.
    Front Immunol; 2023 Dec 15; 14():1167965. PubMed ID: 37781368
    [Abstract] [Full Text] [Related]

  • 7. The Glycosylphosphatidylinositol-Anchored Variable Region of Llama Heavy Chain-Only Antibody JM4 Efficiently Blocks both Cell-Free and T Cell-T Cell Transmission of Human Immunodeficiency Virus Type 1.
    Liu L, Wang W, Matz J, Ye C, Bracq L, Delon J, Kimata JT, Chen Z, Benichou S, Zhou P.
    J Virol; 2016 Dec 01; 90(23):10642-10659. PubMed ID: 27654286
    [Abstract] [Full Text] [Related]

  • 8. A CCR5+ memory subset within HIV-1-infected primary resting CD4+ T cells is permissive for replication-competent, latently infected viruses in vitro.
    Terahara K, Iwabuchi R, Hosokawa M, Nishikawa Y, Takeyama H, Takahashi Y, Tsunetsugu-Yokota Y.
    BMC Res Notes; 2019 Apr 29; 12(1):242. PubMed ID: 31036079
    [Abstract] [Full Text] [Related]

  • 9. HIV-1 infection and CD4 T cell depletion in the humanized Rag2-/-gamma c-/- (RAG-hu) mouse model.
    Berges BK, Wheat WH, Palmer BE, Connick E, Akkina R.
    Retrovirology; 2006 Nov 01; 3():76. PubMed ID: 17078891
    [Abstract] [Full Text] [Related]

  • 10. Simultaneous Knockout of CXCR4 and CCR5 Genes in CD4+ T Cells via CRISPR/Cas9 Confers Resistance to Both X4- and R5-Tropic Human Immunodeficiency Virus Type 1 Infection.
    Yu S, Yao Y, Xiao H, Li J, Liu Q, Yang Y, Adah D, Lu J, Zhao S, Qin L, Chen X.
    Hum Gene Ther; 2018 Jan 01; 29(1):51-67. PubMed ID: 28599597
    [Abstract] [Full Text] [Related]

  • 11. Engineering HIV-1-resistant T-cells from short-hairpin RNA-expressing hematopoietic stem/progenitor cells in humanized BLT mice.
    Ringpis GE, Shimizu S, Arokium H, Camba-Colón J, Carroll MV, Cortado R, Xie Y, Kim PY, Sahakyan A, Lowe EL, Narukawa M, Kandarian FN, Burke BP, Symonds GP, An DS, Chen IS, Kamata M.
    PLoS One; 2012 Jan 01; 7(12):e53492. PubMed ID: 23300932
    [Abstract] [Full Text] [Related]

  • 12. Engineering HIV-resistant human CD4+ T cells with CXCR4-specific zinc-finger nucleases.
    Wilen CB, Wang J, Tilton JC, Miller JC, Kim KA, Rebar EJ, Sherrill-Mix SA, Patro SC, Secreto AJ, Jordan AP, Lee G, Kahn J, Aye PP, Bunnell BA, Lackner AA, Hoxie JA, Danet-Desnoyers GA, Bushman FD, Riley JL, Gregory PD, June CH, Holmes MC, Doms RW.
    PLoS Pathog; 2011 Apr 01; 7(4):e1002020. PubMed ID: 21533216
    [Abstract] [Full Text] [Related]

  • 13. GPI-anchored single chain Fv--an effective way to capture transiently-exposed neutralization epitopes on HIV-1 envelope spike.
    Wen M, Arora R, Wang H, Liu L, Kimata JT, Zhou P.
    Retrovirology; 2010 Oct 06; 7():79. PubMed ID: 20923574
    [Abstract] [Full Text] [Related]

  • 14. Humanized mice dually challenged with R5 and X4 HIV-1 show preferential R5 viremia and restricted X4 infection of CCR5(+)CD4(+) T cells.
    Terahara K, Ishige M, Ikeno S, Okada S, Kobayashi-Ishihara M, Ato M, Tsunetsugu-Yokota Y.
    Microbes Infect; 2015 May 06; 17(5):378-86. PubMed ID: 25839960
    [Abstract] [Full Text] [Related]

  • 15. HIV-1 dual/mixed tropic isolates show different genetic and phenotypic characteristics and response to maraviroc in vitro.
    Svicher V, Balestra E, Cento V, Sarmati L, Dori L, Vandenbroucke I, D'Arrigo R, Buonomini AR, Van Marck H, Surdo M, Saccomandi P, Mostmans W, Aerssens J, Aquaro S, Stuyver LJ, Andreoni M, Ceccherini-Silberstein F, Perno CF.
    Antiviral Res; 2011 Apr 06; 90(1):42-53. PubMed ID: 21349294
    [Abstract] [Full Text] [Related]

  • 16. V3 loop-determined coreceptor preference dictates the dynamics of CD4+-T-cell loss in simian-human immunodeficiency virus-infected macaques.
    Ho SH, Shek L, Gettie A, Blanchard J, Cheng-Mayer C.
    J Virol; 2005 Oct 06; 79(19):12296-303. PubMed ID: 16160156
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of dual/mixed tropic HIV-1 isolates by CCR5-inhibitors in primary lymphocytes and macrophages.
    Surdo M, Balestra E, Saccomandi P, Di Santo F, Montano M, Di Carlo D, Sarmati L, Aquaro S, Andreoni M, Svicher V, Perno CF, Ceccherini-Silberstein F.
    PLoS One; 2013 Oct 06; 8(7):e68076. PubMed ID: 23874501
    [Abstract] [Full Text] [Related]

  • 18. CCR5- and CXCR4-tropic HIV-1 are equally cytopathic for their T-cell targets in human lymphoid tissue.
    Grivel JC, Margolis LB.
    Nat Med; 1999 Mar 06; 5(3):344-6. PubMed ID: 10086394
    [Abstract] [Full Text] [Related]

  • 19. Evidence for a post-entry barrier to R5 HIV-1 infection of CD4 memory T cells.
    Vyakarnam A, Eyeson J, Teo I, Zuckerman M, Babaahmady K, Schuitemaker H, Shaunak S, Rostron T, Rowland-Jones S, Simmons G, Clapham P.
    AIDS; 2001 Sep 07; 15(13):1613-26. PubMed ID: 11546935
    [Abstract] [Full Text] [Related]

  • 20. Differences in molecular evolution between switch (R5 to R5X4/X4-tropic) and non-switch (R5-tropic only) HIV-1 populations during infection.
    Mild M, Kvist A, Esbjörnsson J, Karlsson I, Fenyö EM, Medstrand P.
    Infect Genet Evol; 2010 Apr 07; 10(3):356-64. PubMed ID: 19446658
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.